Maternal serum ischemia-modified albumin: a biomarker to distinguish between normal pregnancy and preeclampsia?

@article{Gafsou2010MaternalSI,
  title={Maternal serum ischemia-modified albumin: a biomarker to distinguish between normal pregnancy and preeclampsia?},
  author={Benjamin Gafsou and Guillaume Lef{\`e}vre and Bernadette Hennache and V{\'e}ronique Houfflin Debarge and Anne-Sophie Ducloy-Bouthors},
  journal={Hypertension in pregnancy},
  year={2010},
  volume={29 1},
  pages={
          101-11
        }
}
OBJECTIVE To determine whether a biological marker of ischemia, ischemia-modified albumin (IMA), alone or normalized to albumin serum concentration, was modified during the course of pregnancy and so could be used for discrimination between normal pregnancy and preeclampsia. METHODS Serum IMA concentrations and IMA to serum albumin ratio (IMA/alb) were compared in 22 nonpregnant healthy women (NP), 19 healthy pregnant women (HP) and 20 pre-eclamptic women (PE). Influence of age of gestation… CONTINUE READING
BETA

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 34 REFERENCES

Similar Papers

Loading similar papers…